Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Michael Baum

Showing results (181-190 of 191) with videos related to

Pageof 20
Sort By:
Lancet (London, England)|June 24, 2010
Targeted intraoperative radiotherapy versus whole breast radiotherapy for breast cancer (TARGIT-A trial): an international, prospective, randomised, non-inferiority phase 3 trialJayant S Vaidya, David J Joseph, Jeffrey S Tobias, et al.
BMJ (Clinical Research Ed.)|November 4, 2010
Breast cancer awareness month. Still awaiting screening factsMichael Baum, Hazel Thornton, Peter C Gøtzsche, et al.
Lancet (London, England)|November 15, 2013
Risk-adapted targeted intraoperative radiotherapy versus whole-breast radiotherapy for breast cancer: 5-year results for local control and overall survival from the TARGIT-A randomised trialJayant S Vaidya, Frederik Wenz, Max Bulsara, et al.
Nucleic Acids Research|November 25, 2003
Validation of a novel, fully integrated and flexible microarray benchtop facility for gene expression profilingMichael Baum, Simone Bielau, Nicole Rittner, et al.
Frontiers in Plant Science|January 7, 2021
The Global Durum Wheat Panel (GDP): An International Platform to Identify and Exchange Beneficial AllelesElisabetta Mazzucotelli, Giuseppe Sciara, Anna M Mastrangelo, et al.
British Journal of Cancer|June 3, 2016
Contemporary accuracy of death certificates for coding prostate cancer as a cause of death: Is reliance on death certification good enough? A comparison with blinded review by an independent cause of death evaluation committeeEmma L Turner, Chris Metcalfe, Jenny L Donovan, et al.
BMJ (Clinical Research Ed.)|August 21, 2020
Long term survival and local control outcomes from single dose targeted intraoperative radiotherapy during lumpectomy (TARGIT-IORT) for early breast cancer: TARGIT-A randomised clinical trialJayant S Vaidya, Max Bulsara, Michael Baum, et al.
JAMA Oncology|April 3, 2020
Effect of Delayed Targeted Intraoperative Radiotherapy vs Whole-Breast Radiotherapy on Local Recurrence and Survival: Long-term Results From the TARGIT-A Randomized Clinical Trial in Early Breast CancerJayant S Vaidya, Max Bulsara, Christobel Saunders, et al.
British Journal of Cancer|May 26, 2021
New clinical and biological insights from the international TARGIT-A randomised trial of targeted intraoperative radiotherapy during lumpectomy for breast cancerJayant S Vaidya, Max Bulsara, Michael Baum, et al.
Molecular Plant|August 25, 2020
Mobilizing Crop BiodiversitySusan McCouch, Zahra Katy Navabi, Michael Abberton, et al.
Pageof 20

Showing results (181-190 of 191) with videos related to

Sort By:
Pageof 20
Lancet (London, England)|June 24, 2010
Targeted intraoperative radiotherapy versus whole breast radiotherapy for breast cancer (TARGIT-A trial): an international, prospective, randomised, non-inferiority phase 3 trialJayant S Vaidya, David J Joseph, Jeffrey S Tobias, et al.
BMJ (Clinical Research Ed.)|November 4, 2010
Breast cancer awareness month. Still awaiting screening factsMichael Baum, Hazel Thornton, Peter C Gøtzsche, et al.
Lancet (London, England)|November 15, 2013
Risk-adapted targeted intraoperative radiotherapy versus whole-breast radiotherapy for breast cancer: 5-year results for local control and overall survival from the TARGIT-A randomised trialJayant S Vaidya, Frederik Wenz, Max Bulsara, et al.
Nucleic Acids Research|November 25, 2003
Validation of a novel, fully integrated and flexible microarray benchtop facility for gene expression profilingMichael Baum, Simone Bielau, Nicole Rittner, et al.
Frontiers in Plant Science|January 7, 2021
The Global Durum Wheat Panel (GDP): An International Platform to Identify and Exchange Beneficial AllelesElisabetta Mazzucotelli, Giuseppe Sciara, Anna M Mastrangelo, et al.
British Journal of Cancer|June 3, 2016
Contemporary accuracy of death certificates for coding prostate cancer as a cause of death: Is reliance on death certification good enough? A comparison with blinded review by an independent cause of death evaluation committeeEmma L Turner, Chris Metcalfe, Jenny L Donovan, et al.
BMJ (Clinical Research Ed.)|August 21, 2020
Long term survival and local control outcomes from single dose targeted intraoperative radiotherapy during lumpectomy (TARGIT-IORT) for early breast cancer: TARGIT-A randomised clinical trialJayant S Vaidya, Max Bulsara, Michael Baum, et al.
JAMA Oncology|April 3, 2020
Effect of Delayed Targeted Intraoperative Radiotherapy vs Whole-Breast Radiotherapy on Local Recurrence and Survival: Long-term Results From the TARGIT-A Randomized Clinical Trial in Early Breast CancerJayant S Vaidya, Max Bulsara, Christobel Saunders, et al.
British Journal of Cancer|May 26, 2021
New clinical and biological insights from the international TARGIT-A randomised trial of targeted intraoperative radiotherapy during lumpectomy for breast cancerJayant S Vaidya, Max Bulsara, Michael Baum, et al.
Molecular Plant|August 25, 2020
Mobilizing Crop BiodiversitySusan McCouch, Zahra Katy Navabi, Michael Abberton, et al.
Pageof 20